Burges Salmon advises Edinburgh biotech firm on £9m funding
Reading time: 1 minute
Katie Carter
Burges Salmon has advised cancer therapeutics company Cumulus Oncology Limited on the £9 million funding package it secured from the Scottish National Investment Bank and Eos Advisory.
An Edinburgh-based team from Burges Salmon’s corporate and M&A team advised Cumulus Oncology, led by senior associate Katie Carter, partner Danny Lee, associate Victoria MacAulay and solicitor Scott Patterson.
Ms Carter said: “Cumulus Oncology is a fantastic company that drives scientific innovation and de-risks science. We’ve been working with Cumulus Oncology since 2020 and it has been a pleasure to advise the team on this significant financing which supports the development of cancer research and shines a light on Scotland’s flourishing biotech capabilities.”
Share this article:
Subscribe to our newsletter to not miss articles like this one:
SUBSCRIBE
